Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1-Reference-Cited by-同舟云学术

Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1

Published:2012-02-29 Issue:2 Volume:3 Page:172-182
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Barber-Rotenberg Julie S.¹,Selvanathan Saravana P.¹,Kong Yali¹,Erkizan Hayriye V.¹,Snyder Tara M.²,Hong S. Peter³,Kobs Christina L.³,South Natalie L.³,Summer Steven³,Monroe Philip J.³,Chruszcz Maksymilian⁴,Dobrev Veselin⁵,Tosso Perrer N.¹,Scher Lauren J.¹,Minor Wladek⁴,Brown Milton L.¹,Metallo Steven J.⁵,Üren Aykut¹,Toretsky Jeffrey A.¹

Affiliation:

1. Department of Oncology, Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC USA

2. AMRI, Pharmaceutical and Quality Services, Albany, NY USA

3. Battelle Memorial Institute, Health and Life Sciences, Columbus, OH USA

4. Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA USA

5. Department of Chemistry, Georgetown University, Washington, DC USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organocatalysis for Enantioselective Decarboxylative Nucleophilic Addition Reactions;European Journal of Organic Chemistry;2024-08-19

2. Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma;Journal of Clinical Oncology;2024-07-02

3. Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma;Molecular Cancer Therapeutics;2024-04-24

4. Targeted Therapy for EWS-FLI1 in Ewing Sarcoma;Cancers;2023-08-09

5. Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas;American Society of Clinical Oncology Educational Book;2023-05